13F GuideFiling Basics
What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
AlphaSMO Research GuideRead Guide
CIK: 0001502287
Total reported value
$2.2B
$2.2B
14 檔
4.6%
According to the latest 13F quarterly dataset, StepStone Group LP managed an equity portfolio of $2.2B at the end of Q4 2024, spanning 14 distinct U.S. exchange-listed positions.
StepStone Group LP executed strategic sector rebalancing during Q4 2024, establishing 4 new positions while fully exiting 4 holdings and trimming 1 positions.
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | ✓ | Moneylion Inc | Stock-Other | 46.85% | — | — | |
| 2 | PATH | Uipath Inc - Class A | Stock-Tech | 14.30% | -4.83% | EXIT | |
| 3 | TRDA | Entrada Therapeutics Inc | Stock-Other | 11.51% | -4.37% | — | |
| 4 | DKNG | Draftkings Inc-cl A | Stock-Consumer Disc | 10.47% | -1.68% | EXIT | |
| 5 | OKUR | Onkure Therapeutics Inc-a | Stock-Other | 3.70% | -4.75% | — | |
| 6 | ✓ | Neuehealth Inc | Stock-Other | 3.41% | — | -0.40% | |
| 7 | PHAT | Phathom Pharmaceuticals Inc | Stock-Other | 3.00% | -2.05% | — | |
| 8 | COIN | Coinbase Global Inc -class A | Stock-Financials | 2.88% | — | — | |
| 9 | ✓ | Hillevax Inc | Stock-Other | 1.50% | — | — | |
| 10 | ✓ | Sentinelone Inc | Stock-Other | 0.69% | — | — | |
| 11 | ✓ | Vacasa Inc | Stock-Other | 0.63% | — | — | |
| 12 | TNYA | Tenaya Therapeutics Inc | Stock-Other | 0.58% | -0.13% | — | |
| 13 | GROV | Grove Collaborative Holdings | Stock-Other | 0.46% | -0.21% | — | |
| 14 | METC | Ramaco Resources Inc-a | Stock-Other | 0.03% | — | — |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | ✓ | Moneylion Inc | +37.4% | — | Unchanged |
| 2 | PATH | Uipath Inc - Class A | +8.3% | — | Unchanged |
| 3 | TRDA | Entrada Therapeutics Inc | +7.1% | — | Unchanged |
| 4 | DKNG | Draftkings Inc-cl A | +5.9% | — | Unchanged |
| 5 | OKUR | Onkure Therapeutics Inc-a | +3.7% | NEW | New buy |
| 6 | COIN | Coinbase Global Inc -class A | +2.9% | NEW | New buy |
| 7 | ✓ | Neuehealth Inc | +2.4% | -0.40% | Trim |
| 8 | ✓ | Hillevax Inc | +1% | — | Unchanged |
| 9 | ✓ | Sentinelone Inc | +0.7% | NEW | New buy |
| 10 | ✓ | Vacasa Inc | +0.5% | — | Unchanged |
| 11 | GROV | Grove Collaborative Holdings | +0.3% | — | Unchanged |
| 12 | TNYA | Tenaya Therapeutics Inc | +0.3% | — | Unchanged |
| 13 | PHAT | Phathom Pharmaceuticals Inc | +0.2% | — | Unchanged |
| 14 | METC | Ramaco Resources Inc-a | 0% | NEW | New buy |
| 15 | FRSH | Freshworks Inc-cl A | -0.6% | EXIT | Sold out |
| 16 | RKLB | Rocket Lab Corporation | -6.9% | EXIT | Sold out |
| 17 | RBLX | Roblox CORP -class A | -7.5% | EXIT | Sold out |
| 18 | DNB | Dun & Bradstreet Holdings In | -55.5% | EXIT | Sold out |
According to official SEC Form 13F filings, StepStone Group LP reported a total U.S. public equity portfolio value of $2.2B across 14 disclosed positions in Q4 2024.
During Q4 2024, StepStone Group LP's top holdings by market value included MONEYLION INC (46.9%)、PATH (14.3%)、TRDA (11.5%). The largest single position, MONEYLION INC, represented 46.9% of total portfolio value.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
In terms of portfolio concentration, the top 5 core holdings (including MONEYLION INC, PATH, TRDA) accounted for 4.6% of total reported equity market value during Q4 2024.
Top New Position Initiated
OKUR
市值: $4.2M
Top Position Liquidated / Trimmed
DNB
前期市值: $152.2M
In Q4 2024, StepStone Group LP made 9 total portfolio adjustments, initiating 4 new buys, adding to 0 positions, trimming 1 holdings, and fully liquidating 4 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.